DEFICIENT ANTIPNEUMOCOCCAL POLYSACCHARIDE RESPONSES IN HIV-SEROPOSITIVE PATIENTS

被引:21
作者
LOELIGER, AE
RIJKERS, GT
AERTS, P
BEENTIKTAK, A
HOEPELMAN, AIM
VANDIJK, H
BORLEFFS, JCC
机构
[1] UNIV UTRECHT HOSP,DEPT INTERNAL MED,CLIN IMMUNOL & INFECT DIS SECT,3508 GA UTRECHT,NETHERLANDS
[2] UNIV UTRECHT HOSP,DEPT CLIN MICROBIOL,3508 GA UTRECHT,NETHERLANDS
[3] UNIV UTRECHT HOSP,INFECT DIS LAB,3508 GA UTRECHT,NETHERLANDS
[4] UNIV HOSP CHILDREN & YOUTH,DEPT IMMUNOL,UTRECHT,NETHERLANDS
来源
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY | 1995年 / 12卷 / 01期
关键词
STREPTOCOCCUS PNEUMONIAE; HIV; VACCINATION;
D O I
10.1111/j.1574-695X.1995.tb00171.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In a prospective study, serological responses and opsonic activity towards Streptococcus pneumoniae were measured in 60 HIV-infected patients and 25 controls after the administration of the 23-valent pneumococcal vaccine (Pneumovax(R)). Serum samples were collected before vaccination and at weeks 1, 2, 4, and 12 after vaccination and were tested for the presence of antibodies against a mixture of capsular polysaccharide antigens (pool) and against type 3 and type 4 antigens (PS3 and PS4), using an ELISA. A serological response was defined as a two-fold or greater increase in serum titer after vaccination. Opsonophagocytosis was measured in patients with a definite response against PS3. Generally, prevaccination antipneumococcal antibody titers were clearly higher in HIV-infected patients than in healthy controls. After vaccination, antipool antibody responses were found in 76% of vaccinated patients; 24% of the patients were non-responders. In patients with more than 0.300 X 10(9) CD4+ cells per liter the percentage of responders was 94%; in patients with fewer than 0.300 X 10(9) CD4+ cells per liter this percentage was 68% (P < 0.05). The antipool response in control subjects was 92%. A serological response to PS3 and PS4 was found in 29% and 49% of the patients, respectively, and was correlated with CD4+ cell count. In controls, these percentages were 48% and 92%, respectively. In 30% of responding patients, antibody titers dropped already to prevaccination levels by week 12 after vaccination. Opsonophagocytosis was not significantly improved by vaccination, probably because of a relatively high preexisting opsonic activity. Although prevaccination conditions may have had an important influence on the study outcome, the results are not in favor of a significant beneficial effect of vaccination with Pneumovax(R) on antibody formation in HN-infected patients. This raises further questions as to the relevance of pneumococcal vaccination in this population.
引用
收藏
页码:33 / 41
页数:9
相关论文
empty
未找到相关数据